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Mutations in hns, the gene encoding the nucleoid-associated protein H-NS, affect both the expression of
many specific unlinked genes and the inversion rate of the DNA segment containing the piL4 promoter in
Escherichia col. A second-site mutation, termed hscAl, compensated for the effect of an hns-1 mutant allele on
the piL4 promoter inversion rate and on activation of the bgl operon. The proU operon, induced in an hns-1
background, remained derepressed in an hns-1 hscAl strain and was induced at an intermediate level in an hns
hscAl strain. An insertion mutant allele, hscA2-cat, conferred the same partial hns-l compensatory phenotype
as the hscAl allele. The hscA gene encoded a 66-kDa protein product that is a member of the Hsp7O protein
class. The gene encoding this product is part of a bicistronic operon that is preceded by a possible r32 promoter
and also encodes a 21-kDa protein with significant homology to the DnaJ protein family. The mutation defining
the hscAl allele resulted in a phenylalanine substituting a conserved serine residue located in the ATP-binding
region of other Hsp7O proteins.
H-NS (H1) is an approximately 16-kDa neutral protein that
is a major nucleoid component in Escherichia coli (10, 35).
Homodimers of this protein bind tightly to double-stranded
DNA, conferring increased thermal stability to the double-
stranded DNA substrate (10, 13, 35). Although H-NS does not
appear to bind DNA in a sequence-dependent fashion (32),
this protein has a higher affinity for curved DNA than for DNA
substrates with similar sequences that do not possess intrinsic
curvature (30, 40). H-NS is expressed at high levels in E. coli,
as each cell contains approximately 20,000 copies of this
protein (35). However, H-NS expression is further induced at
least threefold following cold shock (22). The H-NS protein
has the additional property of acting to inhibit the expression
of a subset of specific genes that are not linked on the E. coli
chromosome (3, 17, 42). Consequently, a number of biological
properties can be attributed to this one small protein: it is a
part of the prokaryotic nucleoid, it is a stress response protein,
and it has an important role in modulating gene expression.
Mutations in hns, the gene encoding H-NS, affect gene
expression and site-specific DNA inversion in E. coli (7, 12, 24,
36, 42), Salmonella strains (15), and Shigella strains (9, 23). In
E. coli hns mutants, the inversion rate of the DNA segment
containing the pilA promoter is increased over 100-fold (18),
the normally cryptic bgl operon is activated (7, 15), the proU
operon (normally expressed only under conditions of high
osmolarity) is derepressed (15, 24), and Pap pilus expression is
also derepressed in strains containing an intactpap locus (12).
Different hns mutant alleles display these same phenotypes,
but the specific mechanism by which these phenotypes are
induced has been the subject of much debate. A number of
studies with Salmonella strains have shown that hns mutations
result in an increased level of negative supercoiling in reporter
plasmids and that this increased negative supercoiling is re-
* Corresponding author. Phone: (919) 966-2637. Fax: (919) 962-
8103. Electronic mail address: Kawula@uncvxl.oit.unc.edu.
sponsible for derepressing proU expression in the absence of
osmotic shock (15, 17, 30). However, H-NS also specifically
inhibits initiation of proU transcription in vitro by directly
binding the proU promoter (38). Furthermore, different hns
alleles confer the same mutant phenotypes without altering the
superhelical density of reporter plasmids (18, 41). Clearly,
under some conditions, a subset of hns mutant alleles have
unpredictable effects on DNA supercoiling levels. It is also
evident that these changes in DNA topology may not account
for all of the phenotypes associated with hns mutations. This
possibility is particularly compelling for the effect of hns
mutations on the DNA inversion rate in E. coli. Two different
mutant hns alleles, hns-1 and hns-2-tetR (formerly termed
pilGl and pilG2-tetR respectively [18]), cause a 100-fold-
increased inversion rate for the 314-bp invertible DNA seg-
ment containing the promoter of thepiLA gene in E. coli. These
two mutant alleles have no discernible effect on reporter
plasmid superhelical density (18). It is reasonable to conclude
that H-NS may affect gene expression and DNA inversion by a
variety of mechanisms.
We have begun to dissect the mechanism by which H-NS is
involved in modulating gene expression and DNA inversion by
isolating second-site mutations that compensate for hns-1
mutant phenotypes in E. coli. Specifically, we have looked for
mutations that restore wild-type, or nearly wild-type, piL4
promoter inversion frequency in an hns-1 mutant background
and then assessed the effect of these second-site compensatory
mutations on other phenotypes associated with hns mutations.
In this study we describe one such mutation defining an allele
termed hscAl that compensated for promoter inversion fre-
quency and bgl activation, but not proU derepression, in an
hns-1 strain. It has been presumed for some time that DnaK is
the only member of the Hsp7O family of shock response
proteins expressed in E. coli. However, the lesion conferring
the hscAl phenotype was in a gene encoding a second Hsp7O
protein that has yet to be described in E. coli.
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TABLE 1. Bacteria, bacteriophages, and plasmids
Strain, phage, Description Source or reference
or plasmid






thr leu proA2 A(argF-lac)U169 galK his argE rpsL supE mtl xyl recBC
sbcB (has TnlO between hsd and serB)
thr-1 leuB thi-1 A(argF-lac)U169 malAl xyl-7 ara-13 mtl-2 gal-6 rpsL
fhuA2 supE44 hns-I F(pilA'-lacZYA-kan)
thr-1 leuB thi-I A(argF-lac)U169 maLAl xyl-7 ara-13 mtl-2 gal-6 rpsL
fhuA2 trpA62 supE44 hns-1 'F(pilA'-lacZYA-kan)zcg::Tn1O
Same as ORN116, except tetR adjacent to hns+ allele
Same as ORN116, except tetR adjacent to hns-1 allele
Same as ORN132, except hscAl
Same as ORN115, except tetR adjacent to hns+ allele
Same as THK35, except is Tets
Same as THK46, except mal+
Same as ORN116, except hscAl zfg::TnlO
Same as THK46, except piLA+ and has TnlO between fimB and fimE
Same as THK38, except 41(proU'-lacZYA-kan)
Same as ORN115, except tetR adjacent to hns-1
Same as THK63, except F(proU'-lacZYA-kan)
Same as THK55, except 17(proU'-lacZYA kan)
Same as THK55, except is Tet5
Same as THK68, except tetR adjacent to hns+ allele
Same as THK68, except tetR adjacent to hns-1 allele
Same as THK72, except 4'(proU'-lacZYA-kan)





pUC19 with 5.4-kb EcoRI fragment from Kohara phage 430; hscA+
pUC19 with 3.35-kb partial HindIII-EcoRI fragment from pTHK200
insert; hscA+
pUC19 with 1.85-kb HpaI-EcoRI fragment from pTHK200; hscA
mutant
pUC19 with 1.5-kb partial HindIII-HpaI fragment from pTHK200;
hscA mutant
pUC19 with 3.0-kb StuI-EcoRI fragment from pTHK200; hscA+












UV mutagenesis of ORN132
P1 transduction from THK31
Bochner selection of THK35 (4)
Selected on MinA maltose
P1 transduction from pooled tetracycline-
resistant THK46 resulting from A::TnlO
infection
P1 transduction from AF249 (P. Orndorff)
P1 transduction from GM50
P1 transduction from THK32
P1 transduction from GM50
P1 transduction from GM50
Bochner selection of THK55 (4)
P1 transduction from THK31
P1 transduction from THK32
P1 transduction from GM50
P1 transduction from GM50




This study (Fig. 3)
This study (Fig. 3)
This study (Fig. 3)
This study (Fig. 3)
This study (Fig. 3)
This study (Fig. 3)
G. Walker
MATERIALS AND METHODS
Bacterial strains, plasmids, and genetic techniques. The
bacterial strains, bacteriophage strains, and plasmids used in
this study are listed in Table 1. Generalized transductions using
P1 vir were carried out as described previously (27). Mutant
alleles constructed in vitro were introduced into the E. coli
chromosome via electroporation with linear DNA into strain
ORN154 (recBC sbcB) as described previously (18). UV mu-
tagenesis of E. coli 0RN132 was performed as described
elsewhere (27). Briefly, cells from 5 ml of a late-log-phase
culture were pelleted and resuspended in 2.5 ml of 10 mM
MgSO4. The cell suspension was subjected to 1,000 ergs ofUV
irradiation. Irradiated cells were plated onto lactose Mac-
Conkey plates and incubated at 30°C. Survivors were assessed
for phenotype with respect to the piLA promoter inversion rate.
Mutations that conferred reduced promoter inversion fre-
quency in the hns-I background were ultimately transduced
into nonmutagenized strains to ensure that resulting pheno-
types were not due to multiple lesions. The pilA promoter
inversion frequencies were calculated as described previously
(29).
Mapping the hscA allele. The hscA allele was located to
approximately 54.5 min on the E. coli chromosome map. A
tetracycline-sensitive, mal+ THK35 derivative (hscAl),
THK47, was infected with A::TnlO. A P1 lysate was made with
the pooled resulting tetracycline-resistant colonies. This lysate
was used to transduce strain ORN116 (hns-1 pilA'-lacZYA-
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phenotype at 30°C on lactose MacConkey agar. Tetracycline-
resistant recipients showing reduced pilA promoter inversion
frequency were picked to determine linkage between the TnlO
insertion and the hscAi allele. One such strain, THK51, had
TnlO 20% linked to hscA1 as determined by P1 cotransduction
analysis. This result also confirmed that a single mutation
conferred the hscAl phenotype. Chromosomal DNA was
prepared from strain THK51, cut with BamHI restriction
endonuclease, electrophoresed on agarose, transferred to ny-
lon, and probed with purified DNA containing a tetR gene.
Restriction endonuclease BamHI cuts TnlO such that the
intact tetR gene was excised along with chromosomal DNA
flanking a TnlO insert. An approximately 7-kb BamHI frag-
ment from THK51 DNA that hybridized to the tetR gene was
identified. Size-fractionated, BamHI-digested THK51 DNA
was ligated into pUC19. Ligation products were transformed
into E. coli DH5ot, selecting for tetracycline resistance. One
such transformant contained pUC19 with a 7.0-kb insert that
hybridized to the tetR gene. This cloned fragment containing
approximately 1 kb of chromosomal DNA flanking the original
TnlO insertion was radiolabeled and used to probe the entire
Kohara clone miniset (20) (Takara Biomedicals). The cloned
DNA hybridized to Kohara phage clones 432 and 433, corre-
sponding to approximately 55 min on the E. coli chromosome
(20).
Media, enzymes, and chemicals. Media consisted of L agar,
L broth, and MacConkey agar (Difco Laboratories, Detroit,
Mich.) and minimal broth (27). When used, antibiotics were
added to final concentrations of 100 ,ug (ampicillin), 20 ,ug
(tetracycline), or 40 ,ug (kanamycin) per ml of medium.
Chemicals and antibiotics were purchased from Sigma Chem-
icals (St. Louis, Mo.). Restriction and other DNA-modifying
enzymes were used according to the manufacturer's recom-
mendations (GIBCO-BRL, Gaithersburg, Md.). P-Galactosi-
dase assays were performed essentially as described elsewhere
(27) on cultures grown in minimal media to an A600 of ca. 0.1
to 0.3. The in vitro transcription-translation reactions using
plasmid DNA templates were performed with E. coli S-30
extracts (Promega) under the conditions recommended by the
manufacturer.
DNA sequencing and analysis. Plasmid clones containing
the hscA allele were sequenced with synthetic oligonucleotides
as primers for double-stranded dideoxy sequencing by using
Sequenase as described by the manufacturer (United States
Biochemical, Cleveland, Ohio). Synthetic oligonucleotides cor-
responding to the wild-type hscA sequence were used as
primers to amplify 400- to 500-bp regions from strain THK47
(hscAl). Overlapping fragments that collectively encompassed
the entire hscA locus were generated. These amplified seg-
ments were cloned into pUC19, and their sequences were
determined as described above. Multiple templates were used
for each amplified fragment to ensure that the hscAi mutation
was assigned properly. Sequences were analyzed by using the
Genetics Computer Group DNA and protein sequence analy-
sis programs (8). Homology between the hscA gene product
and the Hsp7O signature sequences was found by using the
motif program (Genetics Computer Group) for searching the
Prosite data base.
Nucleotide sequence accession number. The DNA sequence
of hscA and 769 flanking bases has been deposited in the
GenBank data base under accession number V01827. The
small open reading frame (ORF) preceding the hscA gene is
identified in the data base submission and has been designated
yfhE by National Center for Biotechnology Information, Gen-
Bank.




On -> off Off -* on
ORN131 (hns+) 4.0 X 10-4 1.4 X 10-3
0RN132 (hns-l)b 1.5 x 10-2 3.2 x 10-2
THK46 (hns-i hscAl) 4.0 X 10-3 6.5 X 10-3
" Variation rates were calculated as described in Materials and Methods and
are expressed as switches per cell per generation.
b The inversion frequency for ORN132 was calculated previously (18).
RESULTS
A second-site compensatory mutation, hscAl, confers re-
duced piUA promoter inversion frequency in an hns-1 mutant
background. Type 1 pilus expression is subject to reversible
on-to-off phase variation. This phase variation is mediated
predominantly by the orientation of a 314-bp DNA segment
containing the promoter for the pilA gene (1, 19). The pitA
gene encodes pilin, the major protein subunit of the type 1
pilus. Using strains containing a piL4'-lacZYA-kan transcrip-
tional fusion allows us to assay piU4 promoter orientations by
colony phenotype on lactose MacConkey agar plates. Cells
with the promoter in the on orientation form red colonies, and
cells with the promoter in the off orientation form white
colonies (29). E. coli pitA'-lacZYA-kan strains containing mu-
tant hns alleles form pink colonies on lactose MacConkey
plates. In these strains the piUA promoter inversion rate is so
rapid that their colonies are composed of an approximately
equal mixture of cells with the piUA promoter in each orienta-
tion (18). Thus, every colony generated by these strains
contains a mixed population of Lac' and Lac - cells. The hns-1
allele confers the rapid inversion phenotype at 30 but not 42°C
because of a mutation in the hns promoter sequence (18, 36).
Consequently, all assays were performed at 30°C. E. coli
ORN132 (pilA'-lacZYA-kan hns-1) was subjected to UV mu-
tagenesis and then screened for reduced pilA promoter inver-
sion frequency phenotype by looking for red or white colonies
on lactose MacConkey plates at 30°C. We isolated one such
mutant, termed THK35, with reduced piUA promoter inversion
frequency at 30°C (Table 2). Using P1 vir cotransduction
analysis, we found that the lesion in this mutated strain did not
map to either the hns or the piL4 region of the chromosome.
The allele defining the hns-I compensatory phenotype was
called hscA1 since this gene encodes a heat shock cognate (see
results below). We found that hscA4 did not suppress the rapid
piLU promoter inversion conferred by the hns insertion mutant
allele hns-2-tetR (data not shown). Also, the hscAl mutation
did not affect promoter inversion in a wild-type hns strain (data
not shown).
The hscAl allele suppresses the effect ofhns-l on bglGFB but
not proU expression. The bglGFB operon, which encodes
products necessary for metabolizing salacin, is normally cryptic
in E. coli. Mutations in hns result in activation of bglGFB
expression (7). Strains containing an activated bgl operon were
detected phenotypically on L agar containing the colorimetric
indicator 5-bromo-4-chloro-3-indolyl-,3-D-glucopyranoside (X-
Gluc). Under these conditions, strains with activated bgl will
hydrolyze the X-Gluc and form blue colonies, whereas nonac-
tivated strains form white colonies. As reported previously,
hns-i mutant strains demonstrated activated bgl (blue colonies
on X-Gluc) at 30 but not 42°C (white colonies) (18). Strains
containing both the hns-i and hscAl alleles together or the
hscAl allele alone had repressed or deactivated bgl expression.
J. BACTERIOL.
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FIG. 1. Effect of hscA mutant alleles on proU expression. Strains with the indicated relevant genotypes and containing a proU-lacZ
transcriptional fusion were grown to mid-log phase at 30°C and then assayed for levels of ,B-galactosidase as described previously (27).
1-Galactosidase levels are expressed as Miller units. The data shown represent the average of results from three independent experiments.
Therefore, hscAl compensated for the hns-1 mutant pheno-
type with regard to bgl activation.
The proU operon is normally repressed under conditions of
low salt but is induced under conditions of increased osmolar-
ity (25). Various mutant hns alieles result in proU expression
even under low-salt conditions (15, 16). Expression of proU
was measured by using a proU'-lacZYA-kan transcriptional
fusion (25). This fusion was moved via P1 transduction into
strains with different hns and hscA alleles (Table 1). As
expected, the hns-1 allele derepressedproU expression (Fig. 1),
which was measured by 3-galactosidase assays performed
during mid-log growth at 30°C in each of strains tested. In the
absence of osmotic induction, proU expression was minimal in
the wild-type hns strain and derepressed in both the hns-1 and
hns-l hscAl strains. Consequently, hscAl did not compensate
forproU derepression in hns-1 mutants. Interestingly,proU was
moderately derepressed in the hns hscAl strain. This increase,
though small, was consistent and reproducible.
Mapping and cloning the hscA allele. To map hscA, we first
isolated a strain with TnlO 20% linked to the hscAl allele
(THK51) as determined by Pl cotransduction frequencies (see
Materials and Methods). Cloned DNA containing the intact
tetR gene plus flanking chromosomal DNA from this strain was
used to probe the Kohara clone miniset (20) (Takara Biomedi-
cals), which represents the entire E. coli chromosome. The
cloned DNA hybridized to Kohara X phage clones 432 and 433,
corresponding to approximately 55 min on the E. coli chromo-
some (21). We then used the TnlO location in THK51 to more
accurately map sinA. Strains containing TnlO at 54, 54.75, and
55.75 min (Table 1) were used as donors to cross the trans-
posons into the tetracycline-sensitive hscAl mutant strain
THK47 via P1 transduction. The cotransduction frequencies
for hscAl and the introduced transposons were determined
(Fig. 2) by transducing a piL4'-1acZYA-kan hns-I recipient,
selecting for tetracycline resistance, and scoring for a reduced
piLA promoter inversion rate. This linkage assessment allowed
us to position the hscA allele between gua-26::TnlO and
zj-208::TnlO. Thus, hscA was at approximately 54.5 min (2) on
the E. coli chromosome.
We obtained a set of Kohara A phage clones encompassing
the E. coli chromosome region determined to contain hscA
(clones 427 to 433 [20]). Each of these Kohara phages was used
to infect strain THK47 (pilA'-lacZYA-kan hns-1 hscA1). In-
fected cells were assessed for conversion from the mutant to
the wild-type hscA phenotype on lactose MacConkey plates.
Kohara clone 430 converted the hscAl allele to wild type in
strain THK47, presumably by allelic exchange. Thus, we sur-
mised that hscA was contained on the phage 430 insert. A
5.4-kb EcoRI fragment from this phage 430 insert cloned into
pUC19 (pTHK200, Fig. 3) suppressed the mutant hscAl
phenotype in trans. Further subcloning and deletion analysis of
pTHK200 allowed us to isolate a 3.4-kb region (pTHK201)
that suppressed the mutant hscAl phenotype (Fig. 3). We
identified two ORFs in this DNA segment which were ar-
ranged in tandem and separated by 16 bases (Fig. 4). There
were no identifiable promoter sequences preceding the second
ORF. The first ORF was preceded by a promoter sequence
with significant homology to E. coli promoters requiring the
alternate u32 RNA polymerase transcription factor (6) (Fig. 4).
Consequently, it is likely that these two genes are part of a
single operon that may be induced in response to stress.
Deleting the 5' end of the first ORF had no effect on the ability
of the remaining cloned DNA, pTHK205, to suppress hscAl.
Also, a pTHK200 derivative, pTHK300 (Fig. 2), containing a
chloramphenicol resistance gene (cat) inserted into a unique
HpaI site in the second ORF (hscA2-cat) did not suppress the
VOL. 176, 1994 613
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FIG. 2. Chromosomal location of the hscA locus as determined by P1 cotransduction. Cotransduction frequencies are expressed as percentages
above the arrows. The arrows point towards the unselected marker. Cotransduction frequencies between two designated TnlO insertions were
determined previously where the unselected TnlO marker had been replaced by TnJO-kan (34). The chromosome map positions are indicated in
minutes on the line above the cotransduction frequencies.
mutant hscA1 phenotype. Therefore, we concluded that the
second ORF represented the hscA allele. When the hscA2-cat
insertion mutant allele was introduced into the E. coli chro-
mosome (Fig. 3), it conferred the same phenotypes described
for the hscAl allele. That is, hscA2-cat resulted in reducedpiL4
promoter inversion frequency in an hns-1 background, yet
proU expression was derepressed independent of the hns
genotype.
The hscA allele encodes an Hsp7O protein. A number of
interesting features were revealed by analyzing the two ORFs,
and the predicted gene products, present on pTHK201. The
firsi ORF, which was not required to suppress hscAl, was
predicted to encode a 21-kDa protein product. By data base
screening, this product showed limited similarity to several
DnaJ-related proteins. Multiple alignment analysis (33) re-
vealed that the protein product contained the most highly
conserved tetrapeptide Y-H-P-D within a 40-amino-acid-resi-
due block conserved in the DnaJ superfamily (21a, 43).
The larger ORF, which was located distal to the first ORF
and required to suppress hscAl, was predicted to encode an
approximately 66-kDa protein product. Plasmid pTHK205
(Fig. 3), which suppressed the hscAl phenotype and contained
only the larger ORF, expressed this 66-kDa protein in a
coupled in vitro transcription-translation assay (Fig. 5). This
product was not made by the pTHK300 plasmid containing the
hscA2-cat insertion mutation (data not shown). The hscA
predicted product amino acid sequence had 42% identity and
62% simnilarity to that of the well-described DnaK Hsp7O
protein of E. coli, and it contained perfect matches to two
amino acid sequences that are conserved among all of the
known Hsp7O proteins (Prosite data base). These sequences
are the octapeptides I-D-L-G-T-T-N-S, beginning at amino
acid position 29, and D-L-G-G-G-T-F-D, beginning at position
212 of the hscA gene product (Fig. 4). The relative positions of
these two sequences in the hscA product are also consistent
with the positioning of these sequences in the characterized
Hsp7O proteins. The second of these octapeptides is thought to
form a part of the ATP-binding domain of Hsp7O proteins
(11). In the E. coli Hsp7O protein DnaK, the threonine located
in this octapeptide (position 199 in DnaK; position 217 in the
hscA product) can be phosphorylated (26). It has been believed
for some time that DnaK was the only Hsp7O protein expressed
in E. coli. However, our evidence indicates that hscA encodes
an additional Hsp7O in this organism.
Repeated attempts to clone the intact hscAl allele failed.
Consequently, to determine the nature of the hscAl mutation,
we sequenced PCR-amplified DNA corresponding to the hscA
allele from a mutant hscAl strain (see Materials and Meth-
ods). The only difference between the wild-type and mutant
hscA sequences was a C-to-T transition at position 1290 in the
hscA1 DNA sequence (Fig. 4). This transition resulted in a
serine-to-phenylalanine substitution in the hscA product. This
serine is conserved in Hsp7O proteins and is located 2 amino
acids away from the ATP-binding octapeptide described
above. Although we do not have direct experimental evidence
that the hscA product binds ATP, a phenylalanine substitution
so near or within an ATP-binding domain might change the
conformation of this region of the protein, thereby dramati-
cally altering its ability to bind or hydrolyze ATP.
DISCUSSION
We have identified a gene, hscA, encoding a new Hsp7O in E.
coli. Both hscA mutant alleles that we studied (hscAl and
hscA2-cat) will compensate for a subset of phenotypes associ-
ated with hns mutations in E. coli. The hscA allele was initially
identified by a mutation conferring reduced piL4 promoter
inversion frequency in an hns-1 mutant. This mutation also
suppressed the effect of hns-I on bgl activation. Further
analysis revealed that this second-site mutation did not sup-
press the effect of hns-1 on proU expression. Paradoxically,
mutations in hscA moderately derepressed proU expression in
wild-type hns strains.
We identified the location of a TnlO insertion linked to
hscAl by hybridizing DNA flanking the transposon to the
Kohara phage miniset. We then mapped hscA more accurately
using a series of TnlO insertions surrounding the region
identified by the Southern hybridizations and used this infor-
mation to select a minimal number of Kohara phage clones to
test for the presence of the wild-type hscA allele. We converted
the mutant hscA1 allele to wild type using Kohara phage 430.
An approximately 3-kb DNA segment cloned from this phage,
pTHK201, suppressed the hscAl phenotype in trans. The DNA
insert on pTHK201 contained two ORFs arranged in tandem
and preceded by a potential &32 promoter. Both ORFs were
expressed in an in vitro coupled transcription-translation assay.
We could not identify a good u70 promoter within 300 bases
proximal to the first ORF on the pTHK200 insert. However,
there is a poor potential u70 promoter located immediately 5'
to the identified &32 promoter sequences. It is likely that the
cloned genes were expressed in vitro from this poor promoter,
a plasmid promoter, or there was enough aJ32 present in the
S-30 extract to allow expression from the a32 promoter.
Expression of the two ORFs should be increased under
J. BAcrERIOL.
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FIG. 3. Cloning the hscA allele and construction of the chromosomal hscA2-cat allele. The Kohara phage 430 insert is oriented clockwise with
respect to the E. coli chromosome map. The plasmid clone pTHK200 contains a 5.4-kb DNA insert from Kohara phage 430 which suppressed the
hscAl phenotype. Phage, plasmid, and strain designations are given in the left column. The phenotype of each construct with respect to the ability
to suppress hscAl in trans is indicated in the column on the right. Vector sequences are designated by solid boxes, and the ORFs determined from
the DNA sequence are designated by the boxes containing slanted lines. The transcription direction of ORFI and hscA is from right to left, which
is counterclockwise with respect to the E. coli chromosome map. A cat gene (encoding chloramphenicol acetyltransferase) was inserted in a unique
HpaI site located 857 bases downstream from the hscA initiation codon. The hscA2-cat insertion mutation was introduced into the E. coli
chromosome via linear transformation into strain ORN105 (recBC sbcB), generating strain THK80.
conditions in which (r32 is more available in the cell, e.g., heat
shock. However, we have not yet been able to detect hscA
transcripts in mRNA prepared from cells prior to or following
heat shock. The genetic evidence indicating that hscA is
expressed in vivo is compelling: (i) two different mutations in
the hscA gene had direct phenotypic effects on cells grown at
30°C, and (ii) a cloned wild-type hscA gene suppressed the
mutant hscAl phenotype in trans. Our inability to detect hscA
mRNA in E. coli may simply reflect that hscA is expressed
poorly under both normal and heat shock conditions.
The second of the two ORFs identified on pTHK201
encoded a 66-kDa protein that was sufficient to suppress the
hscAl phenotype in trans. The amino acid sequence of this
protein has significant homology to the strongly conserved
Hsp7O protein family. This homology includes perfect align-
ment to the two identified signature octapeptides found in all
Hsp7Os to date. These data suggest that hscA encodes an
Hsp7O protein and is a part of a bicistronic stress response
operon in which the hscA gene is preceded by another ORF.
The predicted product of this proximal ORF contains a block
of amino acids with significant homology to the DnaJ family of
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M D Y I T L I G L P A R Y Q L D T Q A L S L R I Q D L Q R Q
201 GTATCATCCT _ vTCAT
Y H P D X F A 8 S8 Q A I Q L A A V Q Q 8 A T I N Q A W Q T L R H
301 CCGTTAATGTCTAGAATGTATTTGCTTTCGrTTCGCGTOACCTAG A
P L M R A Z Y L L 8 L GG F D L A 8 Q H T V R D T A F L X I Q L I
401 A-AGAT GI_=GAAG TC GGTT ACC
L R IZ L D Z II Q A X D Z A R LI S I KX R V X X M I D T R H Q
501GTTGTGGTT_
L M V I Q L D N I T W D A A A D T V R X L R F L D X L R 8 8 A l Q
601 CTCGAkGAAAATGCTcGATTTTTAATTTCT GAATATOGCTGCT C AGCGTCT
L Z KX L L D F * M A L L Q I S I P G L S A A P H Q R R
701 CTG GGCCCATTGGT
L A A G (I D L 0 T T N 8l L V A T V R 8 G Q A I T L A D H 1 G R H L L
801 TGCCATCTGTTGTTCAC TCACaC TTC_GTG T A
P S V V I Y Q Q Q G 8 V G Y D A R T N A A L D T A N T I 8 8 V X
901 ACGCTGTGOGACGCTCGC GACCACATAGCCTTCAT
R L MO R 8 L A D I Q Q R Y P H L P Y Q F Q A 8 N G L PM rI T
1001 GCGGC_GGGCTGCGACCcGTGCGCGTTTCTG TAGTGTAG
A A G L L N P V R V S A D I L X A L A A R A T I A L A IZ L D O V V
1101 TTATCACCGTTCcGGCGGAGTTTCCAaCTTGCACACTTGCTTATAGC
I T V P A Y F D D A Q R Q a T X D A A R L A G L H V L R L L N I P
<T>
1201 GXCCCTGCGCTATCGCCTACGTGGTTCGT
T A A A I A Y G L D S 0 Q 1 0 V I A V Y ED L G G G T F DI I (8) I L R
1301 TTAAGTCOGCIGTGTTTGAATGCTr__a CTGCT
L S R G V F 1 V L A T G G D S A L G O D D F D H L L A D Y I R I Q A
1401 COGGCATTC= _cco=
0 I P D R S D N R V Q R I L L D A A I A A X I A L 8 D A D 8 V T V
1501 TAACGTTGCSaGCTGCACAACCG TGAACAATT _= Ct CS SU
N V A O W Q G Z I 8 R I Q F N I L I A P L V K R T L L A C R R A L
1601 AAAG TGTAGGATA GASSGUGTTGGGCGSGT CTCTT
X D A G V Z A D I V L Z V V M V 0 G 8 T R V P L V R I R V 0 1 F1F
1701 GGTTCICOCTACTTAT
R P P L T S I D P D K V V A I G AA I Q A D I L V G N X P D S M1
1801 GCTGTTGCTTGCCTGTGATCCCACTGTG CCS
L L L D V I P L S L G L Z T MO O L V KX V I P R N T T IP V A R
1901 GCTCAGATTT
A Q D F TT I X D G Q T A M 8 H9 V M Q 0 1 R I L V Q D C R S L A R
2001 GTTw^ _<w _
F A C V V I R R Y R L A O A l I R V T F Q V D A D G L L 8 V T A X
2101 GAG C
1 X S T G V I A S I Q V X 08 Y G L T D 81 I A 8 I X D T M S Y
2201 _= C X _ S _ _ C_GCTGATGCCGCG
A l Q D V X A R M L A I Q X V I A A R V L I S L OG A L A A D A A L
2301 TAT 3&TGTCCCTCCXAC
L S A l R Q V I D D A A A H L S I V A Q O D D V D A l l Q A I X N
2401 __
V D X Q T Q D F A A R R M D Q S V R R A L X O S8 V D V *
2501 TTTATTTTCT CTG TTCT _ _ _ CaTA TAGATC
2601 G TcC














< 43 kd= ~~~< 29 kd
FIG. 5. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis analysis of translation products from hscA4-containing clones.
The plasmids designated above each lane were used as DNA templates
in coupled in vitro transcription-translation reactions (see Materials
and Methods) containing [3 S]methionine to radiolabel protein prod-
ucts. Translation products were electrophoresed on an SDS-12.5%
polyacrylamide gel which was subsequently dried and subjected to
autoradiography. Plasmid pTHK200 expressed three proteins of ca. 21
(open square), 45 (open circle), and 66 (open triangle) kDa not present
in the pUC19 vector control reaction. Plasmid pTHK205, which was
sufficient to suppress hscAl in trans, expressed only the 66-kDa protein.
The 21-kDa product expressed by pTHK200 was encoded by the ORF
immediately preceding the gene encoding the 66-kDa protein. The
additional 45-kDa protein expressed by pTHK200 was encoded by the
2.0-kb DNA segmnent of this clone that we did not sequence. Plasmid
pJM41 containing the dnaKl operon expressed the 69-kDa DnaK
(closed triangle) and 41-kDa DnaJ (closed circle) proteins.
Hsp7O in E. ccli (DnaK) is also part of a bicistronic stress
response operon which contains the dnaJ gene encoding DnaJ
(28). However, in this operon the dna] gene is located distal to
dnaK
The 3' end of the hscA gene was previously sequenced by Ta
and Vickery as DNA flanking thefdx gene in E. ccli (37). Since
writing this report we have learned that the hscA gene has
subsequently been sequenced, expressed, and identified as hsc
by this same group (33a).
The hscAl allele, which suppressed rapid pilA promoter
inversion in hns-i E. ccli, contained a C-to-T transition in a
serine codon that is conserved in Hsp7O proteins (our compar-
ison of Hsp7O amino acid sequences), resulting in a phenylala-
nine in place of the conserved serine. The location is as
informative as the nature of the mutation defining the hscfa1
allele. The serine-to-phenylalanine conversion occurred only 2
amino acids from one of the conserved octapeptides that is in
the region known to be involved in ATP binding by Hsp7O
proteins (11, 39) and 4 amino acids C terminal to the threonine
that can be phosphorylated in E. coli DnaK (26). We have yet
to show experimentally that the hscA product binds ATP.
However, we hypothesize that, by analogy to other Hsp7O
proteins such as DnaK, the serine-to-phenylalanine exchange
could be blocking either ATP binding, hydrolysis, or both by
the hscAl product. While it is clear that Hsp7O proteins bind
and hydrolyze ATP, the functional ramifications of this partic-
ular activity on the biological properties of Hsp7Os are not
totally understood. Mutants deficient in DnaK ATP binding
have phenotypes that closely approximate those associated
with dnaK null mutations (39). Strains containing deletion and
insertion mutations in dnaK are deficient in cell division and
fail to grow at 42°C (5, 31). Strains containing a hscA2-cat
insertion mutant allele on the chromosome grew more slowly
than wild-type hscA strains but were morphologically normal
and viable at 42 as well as 30°C. Consequently, the effect of this
mutation was not nearly as severe as dnaK insertion or deletion
mutations are on cell morphology and growth. It is interesting
to note that we were able to maintain a cloned hscA2-cat
insertion mutation on a high-copy-number vector but have
been unable to clone the hscAl mutant allele. It is possible that
the hscAl mutation confers a dominant lethal phenotype when
present at a high copy number, even in the presence of a
chromosomally located wild-type allele. There is precedence
for this type of mutation in which a dominant lethal phenotype
was conferred by a mutation in the region of the dnaK gene
encoding the ATP-binding domain of this protein (39).
The question of how mutations in hscA compensate for a
subset of hns-1 mutant phenotypes remains. The mutation
defining the hns-1 allele is located in the - 30 region of the hns
promoter (18). This mutation likely results in below-normal
levels of H-NS expression, thus conferring the mutant pheno-
types. It is conceivable that hscA mutations compensate for
hns-1 by effectively raising the amount of available H-NS. This
hypothesis is consistent with our observation that hscA muta-
tions do not compensate for an hns insertion mutation, hns-2-
tetR. However, this possible mechanism does not adequately
explain the fact that hscA mutations not only fail to suppress
the effect of hns-1 on proU derepression but also effectively
derepress proU expression in wild-type hns strains. Since the
hscA product is an Hsp7O protein, models explaining the
activity of hscA must account for both our observed mutant
phenotypes and the biological properties of Hsp7O proteins.
These proteins act as chaperones, binding nascent polypep-
tides and aggregated proteins to promote or restore proper
protein folding (reviewed in reference 14). It has been dem-
onstrated that H-NS may be present in the cell in at least two
different isoforms (35). It is possible that these two H-NS
forms have different biological activities. Perhaps one form is
active in inhibiting pilA promoter inversion, while the other
may function to inhibit proU expression. The hscA product
could function to influence the final conformation of H-NS
towards that inhibitingproU expression. In this case, the lack of
the hscA product in the cell would effectively increase the
amount of the H-NS form active in inhibiting pilA promoter
FIG. 4. Nucleotide sequence of the hscA allele and flanking DNA. The hscA sequence was determined by the dideoxynucleotide method as
described in Materials and Methods. Only the sense strand is shown along with the single-letter amino acid designations for the two ORFs. The
possible a32-dependent promoter sequence preceding the two ORFs is underlined. The two octapeptide amino acid sequences corresponding to
the Hsp7O signature motifs are bracketed in the translated second ORF (hscA). The mutation creating the hscAI allele is indicated by the <T>
placed above the C that it replaced at position 1290. The resulting phenylalanine-for-serine substitution is designated by the (S) corresponding to
the mutated codon.
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inversion while decreasing the amount available to inhibitproU
expression. We are currently testing this hypothesis by assess-
ing the different H-NS forms found in hscA mutant strains.
H-NS has many intriguing properties, such as its role in
nucleoid structure, its effects on DNA topology and gene
expression, and its possible activity as a stress response protein.
Mutations in the gene encoding H-NS result in constitutive
expression or activation of a number of genes typically subject
to some form of environmental regulation. Our isolation of a
second-site mutation that compensates for only a subset of hns
mutant phenotypes provides the first genetic evidence that the
biological activities of H-NS may be modulated by other
cellular components. This compensatory mutation is located in
a gene encoding a new Hsp7O, suggesting a dynamic interac-
tion between H-NS and a possible global stress response
regulon component, thus providing a mechanism for directing
the biological activities of this multifunctional protein.
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